Hamilton Thorne Ltd
XTSX:HTL
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Hamilton Thorne Ltd
XTSX:HTL
|
212.4m CAD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
199.6B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
179.1B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
146.9B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.2B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.8B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.6B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.7B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
51.6B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.7B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Hamilton Thorne Ltd
Glance View
Hamilton Thorne Ltd. engages in the provision of laboratory instruments, consumables, software and services to the assisted reproductive technology (ART) and developmental biology research markets. The company is headquartered in Beverly, Massachusetts. The company went IPO on 2007-07-10. The firm's products lines include precision laser devices, imaging systems, micromanipulation systems, air purification systems, incubators, control rate freezers, and lab monitoring systems. Its GM501 product provides the In Vitro Fertilization (IVF)lab with a cell culture media solution, including oocyte handling, sperm processing, embryo culture, and cryopreservation. Its services offers a range of user needs, ranging from equipment service contract and maintenance programs, quality control testing services to manufacturers of medical devices, culture media and consumables used in IVF labs, and laboratory design and installation services. The firm's brands include Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, and Tek-Event.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Hamilton Thorne Ltd is 51%, which is above its 3-year median of 50.7%.
Over the last 3 years, Hamilton Thorne Ltd’s Gross Margin has decreased from 53.1% to 51%. During this period, it reached a low of 49.3% on Jun 30, 2022 and a high of 53.1% on Jun 30, 2020.
